| Reference : A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than dai... |
| Scientific congresses and symposiums : Paper published in a journal | |||
| Human health sciences : General & internal medicine Human health sciences : Public health, health care sciences & services Human health sciences : Endocrinology, metabolism & nutrition | |||
| http://hdl.handle.net/2268/82392 | |||
| A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than daily oral risedronate 5 mg (RIS) in increasing bone mineral density (BMD) of the lumbar spine (LS), hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (GIO) | |
| English | |
| Reid, D. M. [ > > ] | |
| Devogelaer, Jean-Pierre [ > > ] | |
| Saag, K. [ > > ] | |
| Roux, Christian [ > > ] | |
| Lau, C. S. [ > > ] | |
Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >] | |
| Papanastasiou, P. [ > > ] | |
| Ferreira, A. [ > > ] | |
| Fashola, T. [ > > ] | |
| Sambrook, P. [ > > ] | |
| Apr-2008 | |
| Osteoporosis International | |
| Springer Science & Business Media B.V. | |
| 19 | |
| Suppl.1 | |
| S23-24 | |
| No | |
| International | |
| 0937-941X | |
| 1433-2965 | |
| Godalming | |
| United Kingdom | |
| Eight European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis | |
| du 9 avril 2008 au 12 avril 2008 | |
| WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liège, Belgium and ESCEO | |
| Istanbul | |
| Turkey | |
| http://hdl.handle.net/2268/82392 |
| File(s) associated to this reference | ||||||||||||||
|
Fulltext file(s):
| ||||||||||||||
All documents in ORBi are protected by a user license.